Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

Press/Media

Period	3 Jun 2019

Media coverage

Title	Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision
Media name/outlet	Elk Valley Times
Country/Territory	United States
Date	3/06/19
URL	https://www.elkvalleytimes.com/news/business/secondary-analysis-of-landmark-tailorx-results-published-today-in-the/article_62619004-6273-5d97-aa6d-d6de963e63ad.html
Persons	Joseph Sparano